U.S. flag

An official website of the Department of Health & Human Services

AHRQ: Agency for Healthcare Research and Quality

Search AHRQ

For an exact phrase match, enclose search terms in double quotes.

Go to Advanced Search
Go to Basic Search

Results

Total Results: 543 records

Showing results for "anticoagulant prophylaxis".

  1. Plan Execution

    cmext.ahrq.gov/confluence/pages/viewpage.action?navigatingVersions=true&pageId=114991652
    October 15, 2021 - psychotherapy, long COVID, lung cancer screening) NACHC (potential targets = hypertension/SMBP, long COVID, HIV prophylaxis

  2. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain-2006_executive.pdf
    January 01, 2006 - • Concomitant medication use includes anticoagulants. 3. … Concomitant anticoagulant use • Concomitant use of anticoagulants (e.g., warfarin) and any nonselective … NSAID increases the risk of GI bleeding three- to sixfold compared to anticoagulants alone … • Reliable conclusions about the safety of selective NSAIDs used with anticoagulants are not possible … • Given the large number of patients who meet criteria for aspirin prophylaxis for CV events, more

  3. Layout 1 (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain-2006_executive.pdf
    January 01, 2006 - • Concomitant medication use includes anticoagulants. 3. … Concomitant anticoagulant use • Concomitant use of anticoagulants (e.g., warfarin) and any nonselective … NSAID increases the risk of GI bleeding three- to sixfold compared to anticoagulants alone … • Reliable conclusions about the safety of selective NSAIDs used with anticoagulants are not possible … • Given the large number of patients who meet criteria for aspirin prophylaxis for CV events, more

  4. Using a Computerized Fall Risk Assessment Process to Tailor Interventions in Acute Care (pdf file)

    www.ahrq.gov/downloads/pub/advances2/vol1/advances-hook_25.pdf
    February 26, 2008 - factors: • Metastatic bone disease • Osteoporosis • Antiplatelet agents (except low-dose aspirin) • Anticoagulant … fall event • New medication that increases fall risk (e.g., hypnotic, sedative) or risk for injury (anticoagulant … osteoporosis have both been associated with increased risk of fracture.27 The use of antiplatelet therapy or anticoagulant … Anticoagulant-treated patients who fall and experience loss of consciousness or intracranial bleeding … Low-dose aspirin prophylaxis and risk of intracranial hemorrhage in patients older than 60 years of

  5. Using a Computerized Fall Risk Assessment Process to Tailor Interventions in Acute Care (pdf file)

    www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety-2/vol1/Advances-Hook_25.pdf
    February 26, 2008 - factors: • Metastatic bone disease • Osteoporosis • Antiplatelet agents (except low-dose aspirin) • Anticoagulant … fall event • New medication that increases fall risk (e.g., hypnotic, sedative) or risk for injury (anticoagulant … osteoporosis have both been associated with increased risk of fracture.27 The use of antiplatelet therapy or anticoagulant … Anticoagulant-treated patients who fall and experience loss of consciousness or intracranial bleeding … Low-dose aspirin prophylaxis and risk of intracranial hemorrhage in patients older than 60 years of

  6. Implementation Guide: Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication (pdf file)

    cds.ahrq.gov/sites/default/files/cds/artifact/26/2023_CDS_Connect_IG_Aspirin_Therapy.pdf
    January 01, 2023 - Patient is on another anticoagulant. f. Patient has allergy or intolerance to aspirin. g. … alanine transaminase (ALT) result is > 150 OR diagnosis of thrombocytopenia OR currently receiving an anticoagulant … OR “other medical condition” OR use of medications that increase bleeding risk: Concurrent use of anticoagulant … This new guideline changes the inclusion age range to 40 – 59; the CVD prophylaxis recommendations to

  7. Agency for Healthcare Research and Quality

    www.ahrq.gov/research/findings/studies/index.html?page=267
    January 01, 2024 - Pannucci CJ , Fleming KI , Agarwal J The impact of once- versus twice-daily enoxaparin prophylaxis … The impact of once- versus twice-daily enoxaparin prophylaxis on risk for venous thromboembolism and

  8. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain_executive.pdf
    October 01, 2011 - Concomitant anticoagulant use Moderate overall: Primarily observational studies Concomitant use of anticoagulants … and nonselective NSAIDs increases the risk of GI bleeding three- to six- fold compared with anticoagulant … comparative safety of nonselective, partially selective, and COX-2 selective NSAIDs with concomitant anticoagulants … increased the risk of bleeding compared with warfarin alone in patients with indications for antithrombotic prophylaxis

  9. Layout 1 (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain_executive.pdf
    October 01, 2011 - Concomitant anticoagulant use Moderate overall: Primarily observational studies Concomitant use of anticoagulants … and nonselective NSAIDs increases the risk of GI bleeding three- to six- fold compared with anticoagulant … comparative safety of nonselective, partially selective, and COX-2 selective NSAIDs with concomitant anticoagulants … increased the risk of bleeding compared with warfarin alone in patients with indications for antithrombotic prophylaxis

  10. Plan Execution

    cmext.ahrq.gov/confluence/pages/viewpage.action?pageId=114991539
    October 15, 2021 - psychotherapy, long COVID, lung cancer screening) NACHC (potential targets = hypertension/SMBP, long COVID, HIV prophylaxis

  11. Plan Execution

    cmext.ahrq.gov/confluence/pages/viewpage.action?navigatingVersions=true&pageId=114991539
    October 15, 2021 - psychotherapy, long COVID, lung cancer screening) NACHC (potential targets = hypertension/SMBP, long COVID, HIV prophylaxis

  12. Dental Care for People With Sickle Cell Disease: A Rapid Response Literature Review (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/sickle-cell-dental-rapid-response.pdf
    July 01, 2024 - Further, antibiotic prophylaxis is recommended for invasive dental and major oral surgical procedures … PubMed search history on November 30, 2023 Search Number Query Results 1 "Dental Prophylaxis"[ … Antibiotic prophylaxis is recommended for invasive dental and major oral surgical procedures. … Towards New Frontiers of Direct Oral Anticoagulants: Sickle Cell Disease Acta Haematol, 142(4), 195- … Effects of antiplatelet and anticoagulant medications on the vasoocclusive and thrombotic complications

  13. Dental Care for People With Sickle Cell Disease: A Rapid Response Literature Review (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/sickle-cell-dental-rapid-response.pdf
    July 01, 2024 - Further, antibiotic prophylaxis is recommended for invasive dental and major oral surgical procedures … PubMed search history on November 30, 2023 Search Number Query Results 1 "Dental Prophylaxis"[ … Antibiotic prophylaxis is recommended for invasive dental and major oral surgical procedures. … Towards New Frontiers of Direct Oral Anticoagulants: Sickle Cell Disease Acta Haematol, 142(4), 195- … Effects of antiplatelet and anticoagulant medications on the vasoocclusive and thrombotic complications

  14. Psi90 Factsheet Faq V2 (pdf file)

    qualityindicators.ahrq.gov/News/PSI90_Factsheet_FAQ_V2.pdf
    October 05, 2016 - 12 events in this population may be less preventable due to safety concerns with pharmacological prophylaxis

  15. Psi90 Factsheet Faq V2 (pdf file)

    qualityindicators.ahrq.gov/News/PSI90_Factsheet_FAQ_v2.pdf
    October 05, 2016 - 12 events in this population may be less preventable due to safety concerns with pharmacological prophylaxis

  16. Implementation Guide: Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication (pdf file)

    cds.ahrq.gov/sites/default/files/cds/artifact/26/2024_CDS_Connect_IG_Aspirin_Therapy.pdf
    January 01, 2024 - Patient is on another anticoagulant. 6 f. Patient has allergy or intolerance to aspirin. g. … alanine transaminase (ALT) result is >150 OR diagnosis of thrombocytopenia OR currently receiving an anticoagulant … OR “other medical condition” OR use of medications that increase bleeding risk: Concurrent use of anticoagulant … This new guideline changes the inclusion age range to 40 – 59; the CVD prophylaxis recommendations to

  17. Safe Practices for Better Health Care (pdf file)

    www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol4/Kizer1.pdf
    April 01, 2004 - procedure for his or her risk of surgical site infection (SSI), and implement appropriate antibiotic prophylaxis … all “high alert” drugs (e.g., intravenous adrenergic agonists and antagonists, chemotherapy agents, anticoagulants

  18. Using a Computerized Fall Risk Assessment Process to Tailor Interventions in Acute Care (pdf file)

    ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety-2/vol1/Advances-Hook_25.pdf
    February 26, 2008 - factors: • Metastatic bone disease • Osteoporosis • Antiplatelet agents (except low-dose aspirin) • Anticoagulant … fall event • New medication that increases fall risk (e.g., hypnotic, sedative) or risk for injury (anticoagulant … osteoporosis have both been associated with increased risk of fracture.27 The use of antiplatelet therapy or anticoagulant … Anticoagulant-treated patients who fall and experience loss of consciousness or intracranial bleeding … Low-dose aspirin prophylaxis and risk of intracranial hemorrhage in patients older than 60 years of

  19. Vascular Access Device (VAD) Policy, Adult (pdf file)

    www.ahrq.gov/sites/default/files/wysiwyg/hai/clabsi-tools/vascular-access-device-policy.pdf
    March 01, 2008 - INR or a PTT ratio > 1.3, platelets < 50K) or if patient is on therapeutic dosing of thrombolytics/anticoagulants … The nurse may remove central VAD for patients on anticoagulants for Venous Thromboembolism (VTE) Prophylaxis … The following are considered prophylactic dosing for VTE: Drug Usual prophylaxis dose Heparin 5000

  20. PSI 90 Fact Sheet (pdf file)

    qualityindicators.ahrq.gov/News/PSI90_Factsheet_FAQ_v1.pdf
    August 31, 2016 - 12 events in this population may be less preventable due to safety concerns with pharmacological prophylaxis
SHARE:
Facebook Twitter Print Facebook Share

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

Click to show only results for the selected site.

www.ahrq.gov (106)

psnet.ahrq.gov (62)

cmext.ahrq.gov (60)

effectivehealthcare-admin.ahrq.gov (59)

ce.effectivehealthcare.ahrq.gov (53)

effectivehealthcare.ahrq.gov (46)

www.uspreventiveservicestaskforce.org (20)

www.qualitymeasures.ahrq.gov (17)

digital.ahrq.gov (10)

pbrn.ahrq.gov (8)

pcmh.ahrq.gov (8)

www.cpsi.ahrq.gov (8)

ahrqpubs.ahrq.gov (7)

cahps.ahrq.gov (7)

healthcare411.ahrq.gov (7)

monahrq.ahrq.gov (7)

patientregistry.ahrq.gov (7)

qualityindicators.ahrq.gov (6)

talkingquality.ahrq.gov (6)

www.cahps.ahrq.gov (6)

preventiveservices.ahrq.gov (5)

teamstepps.ahrq.gov (5)

www.healthcare411.ahrq.gov (5)

www.innovations.ahrq.gov (5)

www.monahrq.ahrq.gov (5)

www.talkingquality.ahrq.gov (5)

cds.ahrq.gov (3)